Coating Place Inc., a Wisconsin‑based contract development and manufacturing organization specializing in Wurster‑based fluid‑bed microencapsulation, is marking its 50th anniversary with continued expansion efforts and new additions to its executive team.

As part of its ongoing growth strategy, the company announced two new executive appointments: Cara Young, who joins as Vice President of Business Development, and Jeffrey Peterson, who becomes Vice President of Finance.

Young brings more than 25 years of experience in pharmaceutical business development, technical sales, and account management, with a background in building strategic partnerships for complex drug‑product programs. Peterson adds over 25 years of financial leadership experience across manufacturing and operational environments, and will help support the company’s increased investment in sites and capabilities.

Coating Place said the new leadership appointments strengthen its position as demand grows for specialized drug‑delivery systems. Young’s commercial expertise is expected to support an expanding customer base, while Peterson’s financial oversight will guide infrastructure investment aligned with long‑term strategy. The company framed the additions as part of a broader effort to support its next chapter of growth following its half‑century milestone.

New Oral Solid Dose Packaging Line

Coating Place also announced a new investment in oral solid dose bottle packaging at its Verona facility. This addition will include a modest facility redesign to integrate the new line within our existing footprint. The packaging line will support proper handling of scheduled products (CI – CV) and provide customers with a fully integrated solution, including track-and-trace capabilities.

This investment is a key part of Coating Place’s strategy to deliver true end-to-end services  all under one roof. The new facility addition, co-located with the company’s existing GMP development and manufacturing operations, is on track for completion and validation by Q4 2026.